Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur

Christian H. Geisler; Arne Kolstad; Anna Laurell; Mats Jerkeman; Riikka Raty; Niels S. Andersen; Lone B. Pedersen; Mikael Eriksson; Marie Nordstrom; Eva Kimby; Hans Bentzen; Outi Kuittinen; Grete F. Lauritzsen; Herman Nilsson-Ehle; Elisabeth Ralfkiaer; Mats Ehinger; Christer Sundstrom; Jan Delabie; Marja Karjalainen-Lindsberg; Peter Brown; Erkki Elonen; Nordic Lymphoma Grp

doi:10.1111/j.1365-2141.2012.09174.x

Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur

Christian H. Geisler, Arne Kolstad, Anna Laurell, Mats Jerkeman, Riikka Raty, Niels S. Andersen, Lone B. Pedersen, Mikael Eriksson, Marie Nordstrom, Eva Kimby, Hans Bentzen, Outi Kuittinen, Grete F. Lauritzsen, Herman Nilsson-Ehle, Elisabeth Ralfkiaer, Mats Ehinger, Christer Sundstrom, Jan Delabie, Marja Karjalainen-Lindsberg, Peter BrownErkki Elonen, Nordic Lymphoma Grp

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Lehti	British Journal of Haematology
Vuosikerta	158
Numero	3
Sivut	355-362
Sivumäärä	8
ISSN	0007-1048
DOI - pysyväislinkit	https://doi.org/10.1111/j.1365-2141.2012.09174.x
Tila	Julkaistu - 2012
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Lisätietoja

This article has an erratum: http://dx.doi.org/10.1111/bjh.12006

Tieteenalat

3121 Yleislääketiede, sisätaudit ja muut kliiniset lääketieteet

Pääsy asiakirjaan

10.1111/j.1365-2141.2012.09174.x

Siteeraa tätä

Geisler, C. H., Kolstad, A., Laurell, A., Jerkeman, M., Raty, R., Andersen, N. S., Pedersen, L. B., Eriksson, M., Nordstrom, M., Kimby, E., Bentzen, H., Kuittinen, O., Lauritzsen, G. F., Nilsson-Ehle, H., Ralfkiaer, E., Ehinger, M., Sundstrom, C., Delabie, J., Karjalainen-Lindsberg, M., ... Nordic Lymphoma Grp (2012). Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur. British Journal of Haematology, 158(3), 355-362. https://doi.org/10.1111/j.1365-2141.2012.09174.x

Geisler, Christian H. ; Kolstad, Arne ; Laurell, Anna et al. / Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur. Julkaisussa: British Journal of Haematology. 2012 ; Vuosikerta 158, Nro 3. Sivut 355-362.

@article{50a4177c248d499897d0e93e410df15b,

title = "Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur",

keywords = "mantle cell lymphoma, autologous stem cell transplant, high-dose AraC, rituximab, pre-emptive therapy, INTERNATIONAL PROGNOSTIC INDEX, PROGRESSION-FREE SURVIVAL, PROSPECTIVE RANDOMIZED-TRIAL, HIGH-DOSE METHOTREXATE, SEQUENTIAL CHEMOTHERAPY, RESPONSE CRITERIA, RITUXIMAB, TRANSPLANTATION, THERAPY, REMISSION, 3121 General medicine, internal medicine and other clinical medicine",

author = "Geisler, {Christian H.} and Arne Kolstad and Anna Laurell and Mats Jerkeman and Riikka Raty and Andersen, {Niels S.} and Pedersen, {Lone B.} and Mikael Eriksson and Marie Nordstrom and Eva Kimby and Hans Bentzen and Outi Kuittinen and Lauritzsen, {Grete F.} and Herman Nilsson-Ehle and Elisabeth Ralfkiaer and Mats Ehinger and Christer Sundstrom and Jan Delabie and Marja Karjalainen-Lindsberg and Peter Brown and Erkki Elonen and {Nordic Lymphoma Grp}",

note = "This article has an erratum: http://dx.doi.org/10.1111/bjh.12006 ",

year = "2012",

doi = "10.1111/j.1365-2141.2012.09174.x",

language = "English",

volume = "158",

pages = "355--362",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley",

number = "3",

}

Geisler, CH, Kolstad, A, Laurell, A, Jerkeman, M, Raty, R, Andersen, NS, Pedersen, LB, Eriksson, M, Nordstrom, M, Kimby, E, Bentzen, H, Kuittinen, O, Lauritzsen, GF, Nilsson-Ehle, H, Ralfkiaer, E, Ehinger, M, Sundstrom, C, Delabie, J, Karjalainen-Lindsberg, M, Brown, P, Elonen, E & Nordic Lymphoma Grp 2012, 'Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur', British Journal of Haematology, Vuosikerta 158, Nro 3, Sivut 355-362. https://doi.org/10.1111/j.1365-2141.2012.09174.x

Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur. / Geisler, Christian H.; Kolstad, Arne; Laurell, Anna et al.

julkaisussa: British Journal of Haematology, Vuosikerta 158, Nro 3, 2012, s. 355-362.

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur

AU - Geisler, Christian H.

AU - Kolstad, Arne

AU - Laurell, Anna

AU - Jerkeman, Mats

AU - Raty, Riikka

AU - Andersen, Niels S.

AU - Pedersen, Lone B.

AU - Eriksson, Mikael

AU - Nordstrom, Marie

AU - Kimby, Eva

AU - Bentzen, Hans

AU - Kuittinen, Outi

AU - Lauritzsen, Grete F.

AU - Nilsson-Ehle, Herman

AU - Ralfkiaer, Elisabeth

AU - Ehinger, Mats

AU - Sundstrom, Christer

AU - Delabie, Jan

AU - Karjalainen-Lindsberg, Marja

AU - Brown, Peter

AU - Elonen, Erkki

AU - Nordic Lymphoma Grp

N1 - This article has an erratum: http://dx.doi.org/10.1111/bjh.12006

PY - 2012

Y1 - 2012

KW - mantle cell lymphoma

KW - autologous stem cell transplant

KW - high-dose AraC

KW - rituximab

KW - pre-emptive therapy

KW - INTERNATIONAL PROGNOSTIC INDEX

KW - PROGRESSION-FREE SURVIVAL

KW - PROSPECTIVE RANDOMIZED-TRIAL

KW - HIGH-DOSE METHOTREXATE

KW - SEQUENTIAL CHEMOTHERAPY

KW - RESPONSE CRITERIA

KW - RITUXIMAB

KW - TRANSPLANTATION

KW - THERAPY

KW - REMISSION

KW - 3121 General medicine, internal medicine and other clinical medicine

U2 - 10.1111/j.1365-2141.2012.09174.x

DO - 10.1111/j.1365-2141.2012.09174.x

M3 - Article

VL - 158

SP - 355

EP - 362

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -

Geisler CH, Kolstad A, Laurell A, Jerkeman M, Raty R, Andersen NS et al. Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur. British Journal of Haematology. 2012;158(3):355-362. doi: 10.1111/j.1365-2141.2012.09174.x